FDA & Wholesale Drug Distributors
Dylan Desjardins offers ways for the FDA to improve the underlying assumptions, examination of alternatives, and review of unintended consequences for this proposed rule.
Improving regulatory policy
through research, education, and outreach.
Promotes best practices for regulatory analysis
Improves regulatory processes and institutions
Serves as a source for objective information
"The GW Regulatory Studies Center has done phenomenal work in cataloguing and analyzing reforms in regulatory policy...[it is] a national treasure."
Cass R. Sunstein
Robert Walmsley University Professor, Harvard
OIRA Administrator Under President Obama
FDA & Wholesale Drug Distributors
Dylan Desjardins offers ways for the FDA to improve the underlying assumptions, examination of alternatives, and review of unintended consequences for this proposed rule.
Final Report on Contractors in Rulemaking
This report sheds light on the ways that federal agencies use contractors to support the rulemaking process.
In recent years, the Chinese government has increasingly flexed its economic, political, and military muscles around the world. Close to its mainland home has been no exception, as the Chinese government has taken actions to pressure officials in Hong Kong and Taiwan.
"Your input and expertise during the drafting of the Early Participation in Regulations Act of 2019 and SMART Act of 2019 was invaluable."
Joint Statement (PDF)
Senator Kyrsten Sinema (D-AZ)
Senator James Lankford (R-OK)
"The GW Regulatory Studies Center provided me with the analytical skills I needed, and gave me a sense of community as an international student."
— Ana Maria Zárate Moreno
"It is rare to find a situation where you have a community of scholars who are so accomplished all studying regulation in one place."
— Christopher Carrigan
"The GW Regulatory Studies Center gives students hands on experience that I craved when I was in school. Programs like this are simply invaluable."
— Shawne McGibbon